Somagenics

Founded in 2007, Somagenics is a private diagnostics company focused on small RNA analysis. Its core technology is a proprietary PCR-based platform designed for high sensitivity and specificity in detecting miRNAs, which are important biomarkers for various diseases. The company's platform is tailored for both research and potential clinical diagnostic applications, particularly leveraging biofluids like blood or serum for non-invasive testing. Somagenics operates in the growing field of liquid biopsy and molecular diagnostics, aiming to translate RNA signatures into actionable clinical insights.

Proprietary PCR-based platform optimized for sensitive and specific detection of microRNAs and other small RNAs from biofluids and total RNA inputs.

Somagenics competes in the small RNA analysis space with large tool companies (e.g., Thermo Fisher, QIAGEN) offering standard qPCR kits and newer sequencing-based methods. It also faces competition from numerous startups and diagnostic firms developing proprietary liquid biopsy tests, often focusing on cell-free DNA or proteins alongside miRNAs.